Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Incannex Healthcare (IXHL) EPS (Weighted Average and Diluted): 2020-2025

Historic EPS (Weighted Average and Diluted) for Incannex Healthcare (IXHL) over the last 6 years, with Jun 2025 value amounting to -$1.35.

  • Incannex Healthcare's EPS (Weighted Average and Diluted) rose 93.10% to -$0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.06, marking a year-over-year increase of 23.74%. This contributed to the annual value of -$1.35 for FY2025, which is 17.39% down from last year.
  • Per Incannex Healthcare's latest filing, its EPS (Weighted Average and Diluted) stood at -$1.35 for FY2025, which was down 17.39% from -$1.15 recorded in FY2024.
  • Incannex Healthcare's EPS (Weighted Average and Diluted)'s 5-year high stood at -$1.15 during FY2024, with a 5-year trough of -$1.35 in FY2025.
  • For the 3-year period, Incannex Healthcare's EPS (Weighted Average and Diluted) averaged around -$1.27, with its median value being -$1.30 (2023).
  • In the last 5 years, Incannex Healthcare's EPS (Weighted Average and Diluted) crashed by 103.51% in 2021 and then rose by 11.54% in 2024.
  • Yearly analysis of 5 years shows Incannex Healthcare's EPS (Weighted Average and Diluted) stood at -$1.16 in 2021, then decreased by 7.76% to -$1.25 in 2022, then dropped by 4.00% to -$1.30 in 2023, then rose by 11.54% to -$1.15 in 2024, then dropped by 17.39% to -$1.35 in 2025.